english.prescrire.org > Prescrire International > N°5 - March 1993

n°5

March 1993

Issue Contents
Editorial

Biotech is no panacea

p.1-2

Marketing Authorisations


A look back at 1992

p.3-6

Didanosine tablets for oral solution

p.7-10

Zalcitabine (DDC) now available in hospitals

p.9

Apomorphine solution for subcutaneous injection

p.10-11

Subcutaneous infusion is not the ideal solution

p.11

Amorolfine 5% nail lacquer

p.12-14

Zinc gluconate oral solution

p.14-15

Alpha interferons in renal cancer and myeloma

p.16-17

Simvastatin: official approval of unsound indications

p.18-20

Foscarnet and AIDS-related Cytomegalovirus retinitis

p.20-21

Vigabatrin and childhood epilepsy

p.22-23

Mad cows

p.23-24

Adverse Effects


Neonatal risk of methylene blue

p.25

Hepatitis due to labetalol

p.25-26

Psychological disturbances due to corticosteroids in children

p.26

Zipeprol abuse

p.27-28

Lithium and pregnancy

p.28

Side-effects of omeprazole

p.29-30

Drug-associated taste disorders

p.30

Reviews


No routine screening for hypercholesterolaemia in children

p.31-33

The Muscatine study

p.32

Beware of "self-defence" aerosols

p.33-35

How to invert the upper eyelid

p.34

Treatment of Parkinson's disease

p.36-39

Cholesterol: how many deaths?

p.41-42

Outlook


Smoking world

p.40

Black skin, white masks

p.42

Pregnancy and drug therapy of tuberculosis

p.43

Actilyse° washes whitest!

p.43

Acute pyelonephritis in infants

p.43-44

Pharmacology

p.44

Weaning from mechanical ventilation

p.44-45

A textbook on the management of menopause

p.45

Guide to health in Europe

p.45

Drug-induced hepatitis

p.45

Use of LH-RH analogues for unlicensed indications

p.45

Forum


Should recombinant interleukin-2 have been licensed?

p.46

Fragments of glass in eyedrops

p.47

Febrile infants

p.47

European monitoring notebook

p.47

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe